Literature DB >> 17693387

Pioneer round of translation occurs during serum starvation.

Nara Oh1, Kyoung Mi Kim1, Hana Cho1, Junho Choe1, Yoon Ki Kim2.   

Abstract

The pioneer round of translation plays a role in translation initiation of newly spliced and exon junction complex (EJC)-bound mRNAs. Nuclear cap-binding protein complex CBP80/20 binds to those mRNAs at the 5'-end, recruiting translation initiation complex. As a consequence of the pioneer round of translation, the bound EJCs are dissociated from mRNAs and CBP80/20 is replaced by the cytoplasmic cap-binding protein eIF4E. Steady-state translation directed by eIF4E allows for an immediate and rapid response to changes in physiological conditions. Here, we show that nonsense-mediated mRNA decay (NMD), which restricts only to the pioneer round of translation but not to steady-state translation, efficiently occurs even during serum starvation, in which steady-state translation is drastically abolished. Accordingly, CBP80 remains in the nucleus and processing bodies are unaffected in their abundance and number in serum-starved conditions. These results suggest that mRNAs enter the pioneer round of translation during serum starvation and are targeted for NMD if they contain premature termination codons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693387     DOI: 10.1016/j.bbrc.2007.07.169

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response.

Authors:  Lawrence B Gardner
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

2.  Remodeling of the pioneer translation initiation complex involves translation and the karyopherin importin beta.

Authors:  Hanae Sato; Lynne E Maquat
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

3.  Translation initiation on mRNAs bound by nuclear cap-binding protein complex CBP80/20 requires interaction between CBP80/20-dependent translation initiation factor and eukaryotic translation initiation factor 3g.

Authors:  Junho Choe; Nara Oh; Sungjin Park; Ye Kyung Lee; Ok-Kyu Song; Nicolas Locker; Sung-Gil Chi; Yoon Ki Kim
Journal:  J Biol Chem       Date:  2012-04-04       Impact factor: 5.157

4.  The pioneer round of translation: features and functions.

Authors:  Lynne E Maquat; Woan-Yuh Tarn; Olaf Isken
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

5.  A new MIF4G domain-containing protein, CTIF, directs nuclear cap-binding protein CBP80/20-dependent translation.

Authors:  Kyoung Mi Kim; Hana Cho; Kobong Choi; Jaedong Kim; Bong-Woo Kim; Young-Gyu Ko; Sung Key Jang; Yoon Ki Kim
Journal:  Genes Dev       Date:  2009-07-31       Impact factor: 11.361

6.  eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian cells.

Authors:  Simone C Rufener; Oliver Mühlemann
Journal:  Nat Struct Mol Biol       Date:  2013-05-12       Impact factor: 15.369

7.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.

Authors:  Shuibin Lin; Junho Choe; Peng Du; Robinson Triboulet; Richard I Gregory
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

8.  Yeast mRNA cap-binding protein Cbc1/Sto1 is necessary for the rapid reprogramming of translation after hyperosmotic shock.

Authors:  Elena Garre; Lorena Romero-Santacreu; Nikki De Clercq; Nati Blasco-Angulo; Per Sunnerhagen; Paula Alepuz
Journal:  Mol Biol Cell       Date:  2011-11-09       Impact factor: 4.138

Review 9.  Translation initiation mediated by nuclear cap-binding protein complex.

Authors:  Incheol Ryu; Yoon Ki Kim
Journal:  BMB Rep       Date:  2017-04       Impact factor: 4.778

10.  A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent.

Authors:  Ilya M Terenin; Dmitri E Andreev; Sergey E Dmitriev; Ivan N Shatsky
Journal:  Nucleic Acids Res       Date:  2012-12-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.